Literature DB >> 27048451

Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.

Hiang Keat Tan1,2, Paul Damien James1,3, Florence Wong4.   

Abstract

BACKGROUND: Large-volume total paracentesis may result in paracentesis-induced circulatory dysfunction, which is associated with poor outcomes. AIMS: To explore the short- and long-term effects of paracentesis-induced circulatory dysfunction on systemic hemodynamics, renal function and other cirrhosis-related complications in patients with refractory ascites, following subtotal large-volume paracentesis.
METHODS: Patients with cirrhosis and refractory ascites without renal dysfunction had systemic hemodynamics, renal function, and neurohormones (plasma active renin, aldosterone, norepinephrine and angiotensin II) measured pre- and 6 days post-paracentesis. Paracentesis was limited to ≤8 L with 6-8 g of albumin per liter ascites drained. Patients were followed up until transjugular intrahepatic portosystemic shunt insertion, liver transplantation, or death. Paracentesis-induced circulatory dysfunction was defined as >50 % increase in plasma active renin 6 days post-paracentesis.
RESULTS: Fifty-seven patients (mean age 59.0 ± 9.4 years) had mean 6.8 ± 1.8 L of ascites removed with 9 ± 3 g of albumin given/L of ascites drained. Patients were followed up for 715 ± 104 days. Twenty-three patients (40.4 %) developed paracentesis-induced circulatory dysfunction with unchanged serum creatinine on day six, despite worsening of hemodynamics (mean arterial pressure 90 ± 10 mmHg at baseline vs. 84 ± 8 mmHg on day six, p < 0.05). Similar hemodynamic changes were observed among patients without paracentesis-induced circulatory dysfunction. There was no significant difference in the long-term renal function or cirrhosis-related complications between the groups.
CONCLUSION: The occurrence of paracentesis-induced circulatory dysfunction, as defined by plasma active renin, may not have a significant short- and long-term impact on renal function or cirrhosis-related complications in patients with refractory ascites who undergo subtotal paracentesis with albumin infusion.

Entities:  

Keywords:  Ascites; Cirrhosis; Large-volume paracentesis; Paracentesis-induced circulatory dysfunction; Renal failure

Mesh:

Substances:

Year:  2016        PMID: 27048451     DOI: 10.1007/s10620-016-4140-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

1.  Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis.

Authors:  Robert W Schrier; Dmitri Shchekochikhin; Pere Ginès
Journal:  Nephrol Dial Transplant       Date:  2012-04-06       Impact factor: 5.992

Review 2.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

3.  Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis.

Authors:  Pablo Bellot; Juan Carlos García-Pagán; Rubén Francés; Juan G Abraldes; Miguel Navasa; Miguel Pérez-Mateo; José Such; Jaime Bosch
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

4.  Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.

Authors:  K M Peltekian; F Wong; P P Liu; A G Logan; M Sherman; L M Blendis
Journal:  Am J Gastroenterol       Date:  1997-03       Impact factor: 10.864

5.  Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.

Authors:  Mauro Bernardi; Paolo Caraceni; Roberta J Navickis; Mahlon M Wilkes
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

6.  Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass.

Authors:  Nicole Unger; Ingo Lopez Schmidt; Christian Pitt; Martin K Walz; Thomas Philipp; Klaus Mann; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2004-04       Impact factor: 6.664

7.  Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.

Authors:  Susanna Coll; Maria Carme Vila; Lluis Molina; Maria Dolores Gimenez; Carlos Guarner; Ricard Solà
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-03       Impact factor: 2.566

8.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors:  John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

9.  Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.

Authors:  Virendra Singh; Ramesh Kumar; Chander Kanwal Nain; Baljinder Singh; Arun K Sharma
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

Review 10.  Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.

Authors:  Francesco Salerno; Monica Guevara; Mauro Bernardi; Richard Moreau; Florence Wong; Paolo Angeli; Guadalupe Garcia-Tsao; Samuel S Lee
Journal:  Liver Int       Date:  2010-05-21       Impact factor: 5.828

View more
  5 in total

1.  Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?

Authors:  John Carl Hoefs
Journal:  Dig Dis Sci       Date:  2016-08-23       Impact factor: 3.199

2.  Establishing an indwelling peritoneal catheter as a standard procedure for hospitalized patients with ascites: Retrospective data on feasibility, effectiveness and safety.

Authors:  Katharina Stratmann; Daniel Fitting; Stefan Zeuzem; Jörg Bojunga; Jonel Trebicka; Mireen Friedrich-Rust; Georg Dultz
Journal:  United European Gastroenterol J       Date:  2019-04-03       Impact factor: 4.623

Review 3.  Nutrition in Chronic Liver Disease.

Authors:  Yala Kirthi Reddy; Benedict Maliakkal; Uchenna Agbim
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

4.  Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites.

Authors:  Yu Jun Wong; Huey Ming Lum; Pei Ting Tan; Eng Kiong Teo; Jessica Tan; Rahul Kumar; Prem Harichander Thurairajah
Journal:  Singapore Med J       Date:  2021-04-19       Impact factor: 1.858

5.  Paracentesis-induced acute kidney injury in decompensated cirrhosis - prevalence and predictors.

Authors:  Vaibhav Patil; Mayank Jain; Jayanthi Venkataraman
Journal:  Clin Exp Hepatol       Date:  2019-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.